Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Claudia Huang
Hutchmed Limited
Study Director - Jonathan B Cohen, MD
Emory Winship Cancer Institute
Principal Investigator - Nilanjan Ghosh, MD
Atrium Health Levine Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Helsingin Yliopistollinen Keskussairaala
Helsinki, Finland
- Tampereen Yliopistollinen Sairaala
Tampere, Finland
- Hopital Henri Mondor
Créteil, Val De Marne, France
- Chu de Nantes - Hotel Dieu
Nantes, France
- Chu de Bordeaux - Hôpital Haut-Lévêque
Pessac, France
- Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi Irccs
Bologna, Italy
- Ospedale San Raffaele
Milan, Italy
- Ko-Med Centra Kliniczne
Biała Podlaska, Poland
- Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
- Bioresearch Group Sp. Z. O. O.
Krakow, Poland
- Nasz Lekarz Osrodek Badan Klinicznych
Torun, Poland
- Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza Radeckiego
Wroclaw, Poland
- Ico Badalona - Hospital Universitari Germans Trias I Pujol
Barcelona, Spain
- Ico L'Hospitalet - Hospital Duran I Reynals
Barcelona, Spain
- Fundacion Jimenez Diaz
Madrid, Spain
- Hospital Universitario Virgen Macarena
Seville, Spain
- Hospital Universitario Virgen del Rocio
Seville, Spain
- Innovative Clinical Research Institute
Anaheim, California, United States
- Pacific Cancer Medical Center
Anaheim, California, United States
- Ventura County Hematology-Oncology Specialists
Oxnard, California, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Clinical Research Alliance, Inc
Westbury, New York, United States
- Levine Cancer Institute- Atrium Health
Charlotte, North Carolina, United States
- Baylor Scott and White Research Institute
Dallas, Texas, United States
- Renovatio Clinical
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- Medical Oncology Associates, P.S.
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2019
- Primary completion
- 26 Jun 2024
- Completion
- 26 Jun 2024
- Last update posted
- 26 Jun 2025
- Registered enrollment
- 53
- Registry id
- NCT03786926
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.